ASSOCIATION OF TMEM106B GENE POLYMORPHISMS WITH THE PATHOGENESIS OF ALZHEIMER’S DISEASE

ASSOCIATION OF TMEM106B GENE POLYMORPHISMS WITH THE PATHOGENESIS OF ALZHEIMER’S DISEASE

Objective To investigate the possible role of TMEM106B in Alzheimer’s disease (AD). Methods A total of 308 subjects who were included in the Alzheimer’s disease Neuroimaging Initiative cohort study and underwent TMEM106B rs1990622 genotyping, cerebrospinal fluid (CSF) core protein detection, and neu...

Full description

Bibliographic Details
Main Author:	XIE Tingfei, TAN Lan
Format:	Article
Language:	zho
Published:	Editorial Office of Journal of Precision Medicine 2023-08-01
Series:	精准医学杂志
Subjects:	lysosome-associated membrane glycoproteins\|polymorphism, single nucleotide\|alzheimer disease\|amyloid beta-peptides\|tau proteins
Online Access:	https://jpmed.qdu.edu.cn/fileup/2096-529X/PDF/202304012.pdf

Similar Items

Analysis of early onset of Alzheimer's disease genes: disease causing and risk factors
by: Prama Pandey, et al.
Published: (2021-03-01)

Developments in the Role of Iron Imbalance in the Pathogenesis of Alzheimer's Disease
by: GUO Shuang, CHEN Fengyan, YIN Xiang, WANG Lu, GUO Xuefeng, YU Qiming, ZOU Zhenyou, SHU Wei
Published: (2022-01-01)

The Role of Exosomes as Mediators of Neuroinflammation in the Pathogenesis and Treatment of Alzheimer’s Disease
by: Shiting Weng, et al.
Published: (2022-06-01)

Progress on the correlation between exosomal microRNAs and Alzheimer's disease
by: DIAO Hua-qiong, LI Xiao-li, LIN Liang-yin, LIU Hai-peng, CHEN Hong-jing, DING Hai-yue, WEI Dan
Published: (2020-11-01)

Advantages and Pitfalls in Fluid Biomarkers for Diagnosis of Alzheimer’s Disease
by: Syed Haris Omar, et al.
Published: (2020-07-01)

Dysfunctional Mitochondria and Mitophagy as Drivers of Alzheimer’s Disease Pathogenesis
by: Anushka Chakravorty, et al.
Published: (2019-11-01)

Alzheimer’s disease as an inflammatory disease
by: Bolós Marta, et al.
Published: (2017-02-01)

Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer’s Disease
by: Long Wang, et al.
Published: (2023-11-01)

It's complicated: The relationship between sleep and Alzheimer's disease in humans
by: Brendan P. Lucey
Published: (2020-10-01)

Autophagy and Alzheimer’s Disease: From Molecular Mechanisms to Therapeutic Implications
by: Md. Sahab Uddin, et al.
Published: (2018-01-01)

Impairment of the autophagy–lysosomal pathway in Alzheimer's diseases: Pathogenic mechanisms and therapeutic potential
by: Wei Zhang, et al.
Published: (2022-03-01)

Alzheimer's Disease: The Role of Microglia in Brain Homeostasis and Proteopathy
by: Kevin A. Clayton, et al.
Published: (2017-12-01)

BETA-AMYLOID AS PATHOGENESIS OF ALZHEIMER DISEASE
by: Kadek Ary Mahendri Pattni
Published: (2013-07-01)

Progress in early diagnosis and management of sleep disorder in patients with Alzheimer's disease
by: TANG Shi, et al.
Published: (2021-12-01)

Comparison of potential plasma biomarkers in Alzheimer’s disease and neurodegenerative dementias in Pakistani population
by: Tehniat Faraz Ahmed, et al.
Published: (2023-09-01)

Arginine and Arginine-Rich Peptides as Modulators of Protein Aggregation and Cytotoxicity Associated With Alzheimer’s Disease
by: Somayra S. A. Mamsa, et al.
Published: (2021-10-01)

The 5-lipoxygenase pathway: oxidative and inflammatory contributions to the Alzheimer’s disease pathogenesis
by: Praticò eDomenico, et al.
Published: (2015-01-01)

Review Paper: Tau Pathology of Alzheimer Disease: Possible Role of Sleep Deprivation
by: Nahid Ahmadian, et al.
Published: (2018-09-01)

Synaptic activity and Alzheimer’s disease: a critical update
by: Davide eTampellini
Published: (2015-11-01)

Dityrosine cross-linking and its potential roles in Alzheimer’s disease
by: Mahmoud B. Maina, et al.
Published: (2023-03-01)

Saliva tau and phospho-tau-181 measured by Lumipulse in patients with Alzheimer’s disease
by: Josef Marksteiner, et al.
Published: (2022-09-01)

Amyloid, tau, pathogen infection and antimicrobial protection in Alzheimer’s disease –conformist, nonconformist, and realistic prospects for AD pathogenesis
by: Hongmei Li, et al.
Published: (2018-12-01)

Fluid biomarkers in clinical trials of Alzheimer’s disease therapeutics
by: Aaron eRitter, et al.
Published: (2015-08-01)

Genipin and pyrogallol: Two natural small molecules targeting the modulation of disordered proteins in Alzheimer's disease
by: Sujin Kim, et al.
Published: (2023-12-01)

Synthetic, Cell-Derived, Brain-Derived, and Recombinant β-Amyloid: Modelling Alzheimer’s Disease for Research and Drug Development
by: Kseniya B. Varshavskaya, et al.
Published: (2022-11-01)

Flotillin: A Promising Biomarker for Alzheimer’s Disease
by: Efthalia Angelopoulou, et al.
Published: (2020-03-01)

Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer’s disease related proteins
by: Stephanie R. Oatman, et al.
Published: (2023-01-01)

TMEM106B aggregation in neurodegenerative diseases: linking genetics to function
by: Hai-Shan Jiao, et al.
Published: (2023-08-01)

Impaired Resolution of Inflammation in Alzheimer’s Disease: A Review
by: Robert A. Whittington, et al.
Published: (2017-11-01)

Recent advancements toward therapeutic vaccines against Alzheimer’s disease
by: Krystal Herline, et al.
Published: (2018-08-01)

Insulin Resistance Exacerbates Alzheimer Disease via Multiple Mechanisms
by: Zenghui Wei, et al.
Published: (2021-07-01)

The Cleavage-Specific Tau 12A12mAb Exerts an Anti-Amyloidogenic Action by Modulating the Endocytic and Bioenergetic Pathways in Alzheimer’s Disease Mouse Model
by: Valentina Latina, et al.
Published: (2023-06-01)

Alzheimer’s Disease Pathology in Middle Aged and Older People with HIV: Comparisons with Non-HIV Controls on a Healthy Aging and Alzheimer’s Disease Trajectory and Relationships with Cognitive Function
by: Erin E. Sundermann, et al.
Published: (2023-06-01)

Current advances in the treatment of Alzheimer's disease: focused on considerations targeting Aβ and tau
by: Hong-Qi Yang, et al.
Published: (2012-10-01)

Distinct Molecular Signatures of Amyloid-Beta and Tau in Alzheimer’s Disease Associated with Down Syndrome
by: Shojiro Ichimata, et al.
Published: (2023-07-01)

Obesity and Diabetes Mediated Chronic Inflammation: A Potential Biomarker in Alzheimer’s Disease
by: Md Shahjalal Hossain Khan, et al.
Published: (2020-05-01)

Potential of Sorghum Polyphenols to Prevent and Treat Alzheimer’s Disease: A Review Article
by: Nasim Rezaee, et al.
Published: (2021-10-01)

Linking the Amyloid, Tau, and Mitochondrial Hypotheses of Alzheimer’s Disease and Identifying Promising Drug Targets
by: Zdeněk Fišar
Published: (2022-11-01)

Dreaming of a New World Where Alzheimer’s Is a Treatable Disorder
by: Marcella Catania, et al.
Published: (2019-11-01)

Targeting Microglia in Alzheimer’s Disease: From Molecular Mechanisms to Potential Therapeutic Targets for Small Molecules
by: Ziyad M. Althafar
Published: (2022-06-01)